“UAE’s Health and Pharmaceutical Economic Growth & Innovative

Capacity” Dr.AminHussainAlAmiri.M.Sc,Ph.D.

Asst.UndersecretaryForPublicHealthPolicy&LicensingMinistryofHealth&PrevenAon,UAE

20171U.S-U.A.EBusinessCouncilHealthcare

Event

UAEHealthcareMarket:theStrengths….

UAEhasoneofthemostliberaltraderegimesintheGulfandaCractsstrongcapitalflowsfromacrosstheregion.

UAEisprogressivelydiversifyingitseconomy,whichhasreduceditsvulnerabilitytooilpricemovementscomparedwithotherGulfStates

OneofthemoredevelopedmarketsintheMiddleEast,withstronghealthcareinfrastructureandthehighestpercapitadrugexpenditureintheregion.

Strongpatenteddrugmarket,largelyasaresultofthecountry'spreferenceforthelatestmedicines.

LocalmanufacturingindustryacMvityhasincreasednotablyoverthepastfewyears,withastrongfocusonregionalandglobalexports.

IncreaseinpopulaMonnumbers,includingexpatriates,leadingtosignificantlyhigherhealthcareexpenditureandflourishingtrademarket.

2U.S-U.A.EBusinessCouncilHealthcareEvent

HealthcareInvestmentForecast2015-2025

3

ü  UAE'shealthexpenditurereachedavalueof

AED56.26bn(USD15.32bn)in2015,equaAngtoUSD1,673percapita.

ü  In2016,healthexpenditureincreasedby5%inlocalcurrencyterms,reachingAED59.15bn(USD16.12bn).

ü  ItisforecastedtorisetoAED73.52bn(USD20.03bn)by2020,whichtranslatestoacompoundannualgrowthrate(CAGR)of5.5%.

ü  Overtheextended2016-2025forecastperiod,healthexpenditureisexpectedtorisetoAED101.94bn(USD27.78bn),whichequatestoaCAGRof6.1%

ü  Thegovernment'sshareoftotalhealthexpenditureisexpectedtofalloverourforecastperiodfrom71.3%in2015to60.7%by2025,aligningwiththestrategyofPPPandprivatesectorinvestmentencouragement.

UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ1-2017BMI:BusinessMonitorInterna3onal

U.S-U.A.EBusinessCouncilHealthcareEvent

Facts&Figures:HealthcareProvidersinUAE

U.S-U.A.EBusinessCouncilHealthcareEvent 4

ThereissMllaneedformorePhysicians,nursesandpharmacists;evenwiththecurrentincreaseitisnotkeepingpacewithshiWsinHealthImprovement

StrategyforUAE.

Source:BMIEspicom

PharmaceuMcalMarket:TheUpdates

5

ü  In2015,theUAEpharmaceuAcalmarketreached

avalueofAED8.84bn(USD2.41bn),represenAng15.6%ofhealthcareexpenditure.

ü  In2016themarketreachedavalueofAED9.61bn(USD2.62bn).

ü  By2020,itiscalculatedthatdrugexpenditurewillreachavalueofAED13.13bn(USD3.58bn),equaAngtoacompoundannualgrowthrate(CAGR)of8.2%

ü  by2025,drugexpenditurewillbeworth

AED21.74bn(USD5.92bn)drivenbypopulaAongrowth,achangingdiseaseprofile,andtheuseofmodernmedicinessuchasbiotechnologydrugs.

ü  By2025thepharmaceuAcalmarketwillmakeup0.85%oftheUAE'sGDP,upfrom0.70%in2015.

UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-BMI:BusinessMonitorInterna3onal

UnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-BMI:BusinessMonitorInterna3onal

U.S-U.A.EBusinessCouncilHealthcareEvent

PharmaceuMcalTradeforecast2011-2020

6

v  PharmaceuAcalimportsandexportsstoodatAED8.78bn(USD2.39bn)andAED3.37bn(USD917mn)respecAvelyin2015.

v  ImportswillincreasetoAED14.14bn(USD3.85bn)byend2016andAED17.30bn(USD4.74bn)by2020,atacompoundannualgrowthrate(CAGR)of5.1%

v  ExportsexpectedtorisetoAED3.49bn(USD950mn)byend2016andAED4.14bn(USD1.13bn)by2020-CAGRof4.2%.Ø  UAEimportspharmaceuAcalproductsfrommainly72countries,10countriesaccountforapproximately

80%oftheenAresupply.Ø  ThesecountriesarepredominatelyWesternnaAons(namelytheUK,Switzerland,Germany,Belgium,

France,Spain,ItalyUSAandAustralia)withthedrugscomprisinghigh-valuepatentedproductsUnitedArabEmiratesPharmaceu3cals&HealthcareReportQ12017-

BMI:BusinessMonitorInterna3onal

U.S-U.A.EBusinessCouncilHealthcareEvent

MOHAP:RegulatoryConAnuumLegislaAons&PoliciesDevelopment

MOHAPtogetherwithconcernedstakeholdersdevelopedanumberoflegislaMons(FederalLawsandDecrees).Someexamplesinclude:•  PrivateMedicalHealthFaciliMesFederal

LawNo.(4)fortheyear2015•  MedicalLiabilityFederalLaw(byDecree)

No.(4)fortheYear2016•  OrganTransplantRegulaMonFederalLaw

No.(5)fortheyear2016•  CommunicablediseaseControlFederalLaw

No.(14)fortheyear2014anditsExecuMveDecreeNo.(6)fortheyear2016

•  NaMonalStrategicStockpileDecreeNo.(872)fortheyear2016anditsCabinetExecuMvedecree

7

TrendAnalysis–HealthLegislaAons

MOHAPWebsite

U.S-U.A.EBusinessCouncilHealthcareEvent

MOHAP:RegulatoryConMnuum(cont.)•  EnhancingregulatorypracAcestoensureaccessibilityofacomprehensivequality

healthservicestoallpopulaAonareatthetopofUAEgovernmentagenda

•  Licensing&Monitoring

the3Ps:

•  TheregulaAonofpharmaceuAcalsandmedicaltechnologies/devicesinUAEisaimedto:

Synopsis of Regulations and Licensing Continuum in UAE

8

Ensuringproductsafety,qualityand

effecAveness ProvidingthepublicwithAmelyaccesstogenuinesafeproducts

Premises PracAces Products

U.S-U.A.EBusinessCouncilHealthcareEvent

Professional’QualificaAonRequirements(PQR)

AunifiedguidelinewasdevelopedbytheMinistryofHealthandPrevenMon,HealthAuthority–AbuDhabi(HAAD),andDubaiHealthAuthority(DHA).

ThedocumentsetstheprofessionalqualificaMonrequirementsnecessarytolicensehealthcareprofessionalsintheUAEandtransferoflicenserequirementsacrosstheEmirates.

AlignedwithinternaMonalstandards,thedocumentalsoidenMfiestheminimumacceptablequalificaMonsandexperiencesforeligibilityforlicensuretopracMcemedicalprofession.

9U.S-U.A.EBusinessCouncilHealthcareEvent

NaAonalUnifiedHospitalStandards

HealthRegulatoryAuthoriMesintheUnitedArabEmirates(UAE)representedby:MOHAP,HAADandDHA,developedtheNaMonalUnifiedHospitalStandards-amilestonetowardsfulfillingtheUAEstrategicobjecMvestoimprovethehealthcareserviceprovisionacrossthecountry.

ThisdocumentprovidesabasefortheConcernedAuthoriMestoassesstheperformanceofhospitalstoensuresafeandcompetentdeliveryofservices.

Scope:ThisregulaMonisapplicabletoallhospitalestablishmentsintheUAEthataresubjecttolicensure.Allcategoriesofhospitals,inclusiveofgeneralandspecialtyincludingallgovernmental,semi-governmentalandprivatealongwithhospitalsoperaMnginfreezoneareasexcludingDubaiHealthcareCityAuthorityshallcomplywiththisregulaMon

10U.S-U.A.EBusinessCouncilHealthcareEvent

ProgressofPharmaceuAcalIndustryinUAE

PharmaceuAcalFactories InternaAonalScienAficOffices

11U.S-U.A.EBusinessCouncilHealthcareEvent

12

•  UAE is the only country in theMENA region that adopted an effecMve fast track system forregistraMon of innovator drugs: Fast Track Innovator, which allowed quick access ofinnovatordrugstoUAEpaMents&paMentsfromneighboringcountrieswhoseektreatmentintheUAE.

AccessibilitytoNewTherapies

Harvoni HepaMMsC August2015 Fourth

Tagrisso LungCancer May2016 First

Gardasil HPVVaccine May2016 Second

Synjardy Type2Diabetes May2016 SecondU.S-U.A.EBusinessCouncilHealthcare

Event

13U.S-U.A.EBusinessCouncilHealthcareEvent

National Agenda Vision Focus on:

6)CohesiveSocietyandPreservedIdenAty

1)SafePublicandFairJudiciary

3)CompeAAveKnowledgeEconomy

2)First-RateEducaAonSystem

4)World-ClassHealthcare

5)SustainableEnvironmentandInfrastructure

14U.S-U.A.EBusinessCouncilHealthcareEvent

15

With our Citizens at the heart of development, we strive to become one of

the most competitive countries in the world”

U.S-U.A.EBusinessCouncilHealthcareEvent